+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bevacizumab Biosimilar Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 119 Pages
  • May 2022
  • Region: Global
  • Prof Research
  • ID: 5596582
This report describes the global market size of Bevacizumab Biosimilar from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027.

For the geography segment, regional supply, demand, major players, price is presented from 2017 to 2027.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA

The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Bevacizumab Biosimilar as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • 100mg
  • 400mg

Companies Covered:

  • Pfizer
  • Allergan
  • Alnylam Pharmaceuticals
  • Amgen
  • Angstrom Pharmaceuticals
  • Acceleron Pharma
  • Biocon
  • Bionomics
  • CASI Pharmaceuticals
  • Celgene Corporation
  • Enzon Pharmaceuticals

Base Year: 2022
Historical Data: from 2017 to 2021
Forecast Data: from 2022 to 2027


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
4. Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Bevacizumab Biosimilar Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Bevacizumab Biosimilar Market in North America (2017-2027)
8.1 Bevacizumab Biosimilar Market Size
8.2 Bevacizumab Biosimilar Market by End Use
8.3 Competition by Players/Suppliers
8.4 Bevacizumab Biosimilar Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Bevacizumab Biosimilar Market in South America (2017-2027)
9.1 Bevacizumab Biosimilar Market Size
9.2 Bevacizumab Biosimilar Market by End Use
9.3 Competition by Players/Suppliers
9.4 Bevacizumab Biosimilar Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Bevacizumab Biosimilar Market in Asia & Pacific (2017-2027)
10.1 Bevacizumab Biosimilar Market Size
10.2 Bevacizumab Biosimilar Market by End Use
10.3 Competition by Players/Suppliers
10.4 Bevacizumab Biosimilar Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Bevacizumab Biosimilar Market in Europe (2017-2027)
11.1 Bevacizumab Biosimilar Market Size
11.2 Bevacizumab Biosimilar Market by End Use
11.3 Competition by Players/Suppliers
11.4 Bevacizumab Biosimilar Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Bevacizumab Biosimilar Market in MEA (2017-2027)
12.1 Bevacizumab Biosimilar Market Size
12.2 Bevacizumab Biosimilar Market by End Use
12.3 Competition by Players/Suppliers
12.4 Bevacizumab Biosimilar Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Bevacizumab Biosimilar Market (2017-2022)
13.1 Bevacizumab Biosimilar Market Size
13.2 Bevacizumab Biosimilar Market by End Use
13.3 Competition by Players/Suppliers
13.4 Bevacizumab Biosimilar Market Size by Type
Chapter 14 Global Bevacizumab Biosimilar Market Forecast (2022-2027)
14.1 Bevacizumab Biosimilar Market Size Forecast
14.2 Bevacizumab Biosimilar Application Forecast
14.3 Competition by Players/Suppliers
14.4 Bevacizumab Biosimilar Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Bevacizumab Biosimilar Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.2 Allergan
15.2.1 Company Profile
15.2.2 Main Business and Bevacizumab Biosimilar Information
15.2.3 SWOT Analysis of Allergan
15.2.4 Allergan Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.3 Alnylam Pharmaceuticals
15.3.1 Company Profile
15.3.2 Main Business and Bevacizumab Biosimilar Information
15.3.3 SWOT Analysis of Alnylam Pharmaceuticals
15.3.4 Alnylam Pharmaceuticals Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.4 Amgen
15.4.1 Company Profile
15.4.2 Main Business and Bevacizumab Biosimilar Information
15.4.3 SWOT Analysis of Amgen
15.4.4 Amgen Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.5 Angstrom Pharmaceuticals
15.5.1 Company Profile
15.5.2 Main Business and Bevacizumab Biosimilar Information
15.5.3 SWOT Analysis of Angstrom Pharmaceuticals
15.5.4 Angstrom Pharmaceuticals Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.6 Acceleron Pharma
15.6.1 Company Profile
15.6.2 Main Business and Bevacizumab Biosimilar Information
15.6.3 SWOT Analysis of Acceleron Pharma
15.6.4 Acceleron Pharma Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.7 Biocon
15.7.1 Company Profile
15.7.2 Main Business and Bevacizumab Biosimilar Information
15.7.3 SWOT Analysis of Biocon
15.7.4 Biocon Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.8 Bionomics
15.8.1 Company Profile
15.8.2 Main Business and Bevacizumab Biosimilar Information
15.8.3 SWOT Analysis of Bionomics
15.8.4 Bionomics Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.9 CASI Pharmaceuticals
15.9.1 Company Profile
15.9.2 Main Business and Bevacizumab Biosimilar Information
15.9.3 SWOT Analysis of CASI Pharmaceuticals
15.9.4 CASI Pharmaceuticals Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.10 Celgene Corporation
15.10.1 Company Profile
15.10.2 Main Business and Bevacizumab Biosimilar Information
15.10.3 SWOT Analysis of Celgene Corporation
15.10.4 Celgene Corporation Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
15.11 Enzon Pharmaceuticals
15.11.1 Company Profile
15.11.2 Main Business and Bevacizumab Biosimilar Information
15.11.3 SWOT Analysis of Enzon Pharmaceuticals
15.11.4 Enzon Pharmaceuticals Bevacizumab Biosimilar Revenue, Gross Margin and Market Share (2017-2022)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Bevacizumab Biosimilar Report
Table Data Sources of Bevacizumab Biosimilar Report
Table Major Assumptions of Bevacizumab Biosimilar Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Bevacizumab Biosimilar Picture
Table Bevacizumab Biosimilar Classification
Table Bevacizumab Biosimilar Applications
Table Drivers of Bevacizumab Biosimilar Market
Table Restraints of Bevacizumab Biosimilar Market
Table Opportunities of Bevacizumab Biosimilar Market
Table Threats of Bevacizumab Biosimilar Market
Table Covid-19 Impact For Bevacizumab Biosimilar Market
Table Raw Materials Suppliers
Table Different Production Methods of Bevacizumab Biosimilar
Table Cost Structure Analysis of Bevacizumab Biosimilar
Table Key End Users
Table Latest News of Bevacizumab Biosimilar Market
Table Merger and Acquisition
Table Planned/Future Project of Bevacizumab Biosimilar Market
Table Policy of Bevacizumab Biosimilar Market
Table 2017-2027 North America Bevacizumab Biosimilar Market Size
Figure 2017-2027 North America Bevacizumab Biosimilar Market Size and CAGR
Table 2017-2027 North America Bevacizumab Biosimilar Market Size by Application
Table 2017-2022 North America Bevacizumab Biosimilar Key Players Revenue
Table 2017-2022 North America Bevacizumab Biosimilar Key Players Market Share
Table 2017-2027 North America Bevacizumab Biosimilar Market Size by Type
Table 2017-2027 United States Bevacizumab Biosimilar Market Size
Table 2017-2027 Canada Bevacizumab Biosimilar Market Size
Table 2017-2027 Mexico Bevacizumab Biosimilar Market Size
Table 2017-2027 South America Bevacizumab Biosimilar Market Size
Figure 2017-2027 South America Bevacizumab Biosimilar Market Size and CAGR
Table 2017-2027 South America Bevacizumab Biosimilar Market Size by Application
Table 2017-2022 South America Bevacizumab Biosimilar Key Players Revenue
Table 2017-2022 South America Bevacizumab Biosimilar Key Players Market Share
Table 2017-2027 South America Bevacizumab Biosimilar Market Size by Type
Table 2017-2027 Brazil Bevacizumab Biosimilar Market Size
Table 2017-2027 Argentina Bevacizumab Biosimilar Market Size
Table 2017-2027 Chile Bevacizumab Biosimilar Market Size
Table 2017-2027 Peru Bevacizumab Biosimilar Market Size
Table 2017-2027 Asia & Pacific Bevacizumab Biosimilar Market Size
Figure 2017-2027 Asia & Pacific Bevacizumab Biosimilar Market Size and CAGR
Table 2017-2027 Asia & Pacific Bevacizumab Biosimilar Market Size by Application
Table 2017-2022 Asia & Pacific Bevacizumab Biosimilar Key Players Revenue
Table 2017-2022 Asia & Pacific Bevacizumab Biosimilar Key Players Market Share
Table 2017-2027 Asia & Pacific Bevacizumab Biosimilar Market Size by Type
Table 2017-2027 China Bevacizumab Biosimilar Market Size
Table 2017-2027 India Bevacizumab Biosimilar Market Size
Table 2017-2027 Japan Bevacizumab Biosimilar Market Size
Table 2017-2027 South Korea Bevacizumab Biosimilar Market Size
Table 2017-2027 Southeast Asia Bevacizumab Biosimilar Market Size
Table 2017-2027 Australia Bevacizumab Biosimilar Market Size
Table 2017-2027 Europe Bevacizumab Biosimilar Market Size
Figure 2017-2027 Europe Bevacizumab Biosimilar Market Size and CAGR
Table 2017-2027 Europe Bevacizumab Biosimilar Market Size by Application
Table 2017-2022 Europe Bevacizumab Biosimilar Key Players Revenue
Table 2017-2022 Europe Bevacizumab Biosimilar Key Players Market Share
Table 2017-2027 Europe Bevacizumab Biosimilar Market Size by Type
Table 2017-2027 Germany Bevacizumab Biosimilar Market Size
Table 2017-2027 France Bevacizumab Biosimilar Market Size
Table 2017-2027 United Kingdom Bevacizumab Biosimilar Market Size
Table 2017-2027 Italy Bevacizumab Biosimilar Market Size
Table 2017-2027 Spain Bevacizumab Biosimilar Market Size
Table 2017-2027 Belgium Bevacizumab Biosimilar Market Size
Table 2017-2027 Netherlands Bevacizumab Biosimilar Market Size
Table 2017-2027 Austria Bevacizumab Biosimilar Market Size
Table 2017-2027 Poland Bevacizumab Biosimilar Market Size
Table 2017-2027 Russia Bevacizumab Biosimilar Market Size
Table 2017-2027 MEA Bevacizumab Biosimilar Market Size
Figure 2017-2027 MEA Bevacizumab Biosimilar Market Size and CAGR
Table 2017-2027 MEA Bevacizumab Biosimilar Market Size by Application
Table 2017-2022 MEA Bevacizumab Biosimilar Key Players Revenue
Table 2017-2022 MEA Bevacizumab Biosimilar Key Players Market Share
Table 2017-2027 MEA Bevacizumab Biosimilar Market Size by Type
Table 2017-2027 Egypt Bevacizumab Biosimilar Market Size
Table 2017-2027 Israel Bevacizumab Biosimilar Market Size
Table 2017-2027 South Africa Bevacizumab Biosimilar Market Size
Table 2017-2027 Gulf Cooperation Council Countries Bevacizumab Biosimilar Market Size
Table 2017-2027 Turkey Bevacizumab Biosimilar Market Size
Table 2017-2022 Global Bevacizumab Biosimilar Market Size by Region
Table 2017-2022 Global Bevacizumab Biosimilar Market Size Share by Region
Table 2017-2022 Global Bevacizumab Biosimilar Market Size by Application
Table 2017-2022 Global Bevacizumab Biosimilar Market Share by Application
Table 2017-2022 Global Bevacizumab Biosimilar Key Vendors Revenue
Figure 2017-2022 Global Bevacizumab Biosimilar Market Size and Growth Rate
Table 2017-2022 Global Bevacizumab Biosimilar Key Vendors Market Share
Table 2017-2022 Global Bevacizumab Biosimilar Market Size by Type
Table 2017-2022 Global Bevacizumab Biosimilar Market Share by Type
Table 2022-2027 Global Bevacizumab Biosimilar Market Size by Region
Table 2022-2027 Global Bevacizumab Biosimilar Market Size Share by Region
Table 2022-2027 Global Bevacizumab Biosimilar Market Size by Application
Table 2022-2027 Global Bevacizumab Biosimilar Market Share by Application
Table 2022-2027 Global Bevacizumab Biosimilar Key Vendors Revenue
Figure 2022-2027 Global Bevacizumab Biosimilar Market Size and Growth Rate
Table 2022-2027 Global Bevacizumab Biosimilar Key Vendors Market Share
Table 2022-2027 Global Bevacizumab Biosimilar Market Size by Type
Table 2022-2027 Bevacizumab Biosimilar Global Market Share by Type

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Pfizer
  • Allergan
  • Alnylam Pharmaceuticals
  • Amgen
  • Angstrom Pharmaceuticals
  • Acceleron Pharma
  • Biocon
  • Bionomics
  • CASI Pharmaceuticals
  • Celgene Corporation
  • Enzon Pharmaceuticals

Methodology

Loading
LOADING...